Is Denali Therapeutics Inc. overvalued?

Denali Therapeutics Inc. (DNLI) — key valuation metrics and fundamentals.

No verdict

Price

$25.07

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$3.98B

Dividend yield

0.0%

Return on equity

-55.3%

Sector

Healthcare

Fair value compares DNLI's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks